Evidence map›Paper›PMID 24573273›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

ASIC1a activation enhances inhibition in the basolateral amygdala and reduces anxiety.

Volodymyr I Pidoplichko, Vassiliki Aroniadou-Anderjaska, Eric M Prager, Taiza H Figueiredo, Camila P Almeida-Suhett, Steven L Miller, Maria F M Braga

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. The Slack Channel Regulates Anxiety-Like Behaviors via Basolateral Amygdala Glutamatergic Projections to Ventral Hippocampus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  12. Article
  13. PTSD as an Endothelial Disease: Insights From COVID-19.Frontiers in cellular neuroscience · 2021
    Review
  14. Review
  15. Article
  16. Mechanism and site of action of big dynorphin on ASIC1a.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  17. Article
  18. Human ASIC1a mediates stronger acid-induced responses as compared with mouse ASIC1a.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Volodymyr I PidoplichkoDepartment of Anatomy, Physiology, and Genetics, Department of Psychiatry, and Program in Neuroscience, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814.
Vassiliki Aroniadou-Anderjaska
Eric M Prager
Taiza H Figueiredo
Camila P Almeida-Suhett
Steven L Miller
Maria F M Braga
Pediatrics and Genetics · USUniformed Services University of the Health Sciences · US

Funding

Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and NeuropathologyU01NS058162 · NINDS · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRAGA, MARIA F. · 2006 to 2016
$4.5M
Antiglutamatergic Therapy to Protect the Immature Brain Against Nerve AgentsU01NS102135 · NINDS · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRAGA, MARIA F. · 2018 to 2020
$1.3M
Targeting the Glutamatergic System to Counteract Soman Toxicity in Immature RatsR21NS094131 · NINDS · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRAGA, MARIA F. · 2015 to 2016
$744k
NINDS NIH HHS R21 NS094131NINDS NIH HHS U01 NS058162NINDS NIH HHS U01 NS102135
6 · The paper itself

Abstract

The discovery that even small changes in extracellular acidity can alter the excitability of neuronal networks via activation of acid-sensing ion channels (ASICs) could have therapeutic application in a host of neurological and psychiatric illnesses. Recent evidence suggests that activation of ASIC1a, a subtype of ASICs that is widely distributed in the brain, is necessary for the expression of fear and anxiety. Antagonists of ASIC1a, therefore, have been proposed as a potential treatment for anxiety. The basolateral amygdala (BLA) is central to fear generation, and anxiety disorders are characterized by BLA hyperexcitability. To better understand the role of ASIC1a in anxiety, we attempted to provide a direct assessment of whether ASIC1a activation increases BLA excitability. In rat BLA slices, activation of ASIC1a by low pH or ammonium elicited inward currents in both interneurons and principal neurons, and increased spontaneous IPSCs recorded from principal cells significantly more than spontaneous EPSCs. Epileptiform activity induced by high potassium and low magnesium was suppressed by ammonium. Antagonism of ASIC1a decreased spontaneous IPSCs more than EPSCs, and increased the excitability of the BLA network, as reflected by the pronounced increase of evoked field potentials, suggesting that ASIC1a channels are active in the basal state. In vivo activation or blockade of ASIC1a in the BLA suppressed or increased, respectively, anxiety-like behavior. Thus, in the rat BLA, ASIC1a has an inhibitory and anxiolytic function. The discovery of positive ASIC1a modulators may hold promise for the treatment of anxiety disorders.

Indexed as

Acid Sensing Ion ChannelsAction PotentialsAmmonium CompoundsAmygdalaAnimalsAnti-Inflammatory Agents, Non-SteroidalAnxietyDark AdaptationDisease Models, AnimalExcitatory Amino Acid AntagonistsExploratory BehaviorFlurbiprofenGABA-A Receptor Antagonistsgamma-Aminobutyric AcidHydrogen-Ion ConcentrationInhibitory Postsynaptic PotentialsAcid Sensing Ion ChannelsAmmonium CompoundsAnti-Inflammatory Agents, Non-SteroidalAsic1 protein, ratExcitatory Amino Acid AntagonistsFlurbiprofenGABA-A Receptor Antagonistsgamma-Aminobutyric Acidacid-sensing ion channelsanxietyASIC1abasolateral amygdalaepileptiform activityGABAergic inhibition

Identifiers

PMID24573273
PMCPMC3935079
OpenAlexW2101604013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.